LAWRENCE, Mass., Oct. 6, 2016 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical technology company
focused on advancing renal care, today announced plans to release
its financial results for the third quarter ended September 30, 2016, on Thursday, November 3, 2016, before the opening of
the financial markets.
NxStage will also host a conference call at 9:00 a.m. Eastern Time on Thursday, November 3, 2016 to discuss its third
quarter financial results. To listen to the conference call,
please dial 877-392-9886 (domestic) or 707-287-9329
(international). The call will also be webcast LIVE and can
be accessed via the investor relations section of the Company's
website at http://ir.nxstage.com.
A replay of the conference call will be available two hours
after the completion of the call through November 10, 2016. To access the replay,
dial 855-859-2056 (domestic) or 404-537-3406 (international) and
reference conference ID 94591098. An online archive of the
conference call can be accessed via the investor relations section
of the Company's website at http://ir.nxstage.com.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a leading medical
technology company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. NxStage
also has established a small number of dialysis clinics committed
to the development of innovative care delivery models for patients
with ESRD. For more information on NxStage and its products and
services, please visit the Company's websites at www.nxstage.com
and www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. The forward-looking statements in this Release include
NxStage's plan to release its financial results on November 3, 2016. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including the Quarterly Report on Form 10-Q for the
quarter ended June 30, 2016. NxStage
is under no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or
otherwise.
Contact: Kristen K. Sheppard,
Esq.
VP, Investor Relations
ksheppard@nxstage.com
Logo -
http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-to-report-third-quarter-2016-financial-results-300340526.html
SOURCE NxStage Medical, Inc.